NCT02878967 Standardized Long Term Follow-up of Patients After Endovascular Embolization of a Brain Aneurysm
| NCT ID | NCT02878967 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild |
| Condition | Aneurysm |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2015-11-25 |
| Primary Completion | 2030-11-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2015-11-25 with a primary completion date of 2030-11-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The time-frame and the follow-up elements after embolization of brain aneurysm are not standardized. Therefore, few reliable follow-up data are available for these patients. This study aims at collecting standardized long term data for these patients, in order to assess the occurence of aneurysm recanalization and particularly those requiring another intervention on the aneurysm.
Eligibility Criteria
Inclusion Criteria: * curative embolization of a brain aneurysm * age \>18 years old Exclusion Criteria: * none
Contact & Investigator
Raphaël Blanc, MD
PRINCIPAL INVESTIGATOR
Fondation Ophtalmologique Adolphe de Rothschild
Frequently Asked Questions
Who can join the NCT02878967 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02878967 currently recruiting?
Yes, NCT02878967 is actively recruiting participants. Contact the research team at rblanc@for.paris for enrollment information.
Where is the NCT02878967 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT02878967 clinical trial?
NCT02878967 is sponsored by Fondation Ophtalmologique Adolphe de Rothschild. The principal investigator is Raphaël Blanc, MD at Fondation Ophtalmologique Adolphe de Rothschild. The trial plans to enroll 2,000 participants.